Center for Sleep and Vigilance Disorders, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 8B, Box 421, 40530 Gothenburg, Sweden; Respiratory Department, Sleep Disorders Center, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.
Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Akademiska sjukhuset ing 40, 75185 Uppsala, Sweden; Respiratory Department, The Sleep Apnea Center, Uppsala University Hospital, 75185 Uppsala, Sweden.
Sleep Med Clin. 2021 Sep;16(3):409-416. doi: 10.1016/j.jsmc.2021.05.008. Epub 2021 Jun 1.
The worldwide COVID-19 pandemic has affected the operation of health care systems. The direct impact of obstructive sleep apnea (OSA) on COVID-19 infection outcome remains to be elucidated. However, the coincidence of common risk factors for OSA and severe COVID-19 suggests that patients with OSA receiving positive airway pressure therapy may have an advantage relative to those untreated when confronted with a COVID-19 infection. The ongoing COVID-19 pandemic has led to a substantial reduction of sleep medicine services, and the long-term consequences may be considerable. New strategies for the management of sleep disorders are needed to overcome the current underdiagnosis and delay of treatment.
全球 COVID-19 大流行影响了医疗保健系统的运作。阻塞性睡眠呼吸暂停（OSA）对 COVID-19 感染结果的直接影响仍有待阐明。然而，OSA 和严重 COVID-19 的常见危险因素的巧合表明，与未经治疗的患者相比，接受正压气道通气治疗的 OSA 患者在面对 COVID-19 感染时可能具有优势。持续的 COVID-19 大流行导致睡眠医学服务大幅减少，长期后果可能相当可观。需要新的睡眠障碍管理策略来克服当前的诊断不足和治疗延误。
